Results 171 to 180 of about 20,877 (183)

An open-label, 6-month study of allopurinol safety in gout: The LASSO study

Seminars in Arthritis and Rheumatism, 2015
, Nicola Dalbeth, Scott Baumgartner
exaly  

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis

Rheumatology, 2018
Jeffrey Miner, Ruth Topless, Lisa Stamp   +2 more
exaly  

Anticonvulsant effect of allopurinol on hippocampal-kindled seizures

Pharmacology Biochemistry and Behavior, 1992
Mitsuhiko Nakamura, Nariyoshi Yamaguchi   +1 more
exaly  

The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia – A systematic review and meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases, 2019
Cheng-Wei Liu, , Fu-Shun Hsu
exaly  

A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout

Current Rheumatology Reports, 2009
Robert Terkeltaub, Terkeltaub Robert
exaly  

Allopurinol encapsulated in polycyanoacrylate nanoparticles as potential lysosomatropic carrier: preparation and trypanocidal activity

European Journal of Pharmaceutics and Biopharmaceutics, 2000
Antonio Osuna
exaly  

Allopurinol

Reactions Weekly, 2015
openaire   +1 more source

Allopurinol

2007
S.J. Enna, David B. Bylund
openaire   +1 more source

Allopurinol*

Reactions, 1981
openaire   +1 more source

Clinical Effects of Allopurinol on Intractable Epilepsy

Epilepsia, 1991
exaly